Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rang în acțiuni
#4951
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Preț acțiune
$2.55
Capitalizare de piață
$3.05B
Schimbare (1 zi)
3.33%
Schimbare (1 an)
-11.84%
Țară
CN
Tranzacționează Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Categorie
Healthcare
Raport P/B pentru Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Raport P/B la data de October 2026 TTM: 0.60
Conform celor mai recente rapoarte financiare și prețului acțiunilor Jilin Aodong Pharmaceutical Group Co., Ltd., raportul P/B actual (TTM) este 0.60. La sfârșitul anului 2023, compania avea un P/B de 0.63.
Istoricul raportului P/B pentru Jilin Aodong Pharmaceutical Group Co., Ltd. din 2000 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 0.60 | -13.67% |
| 2024 | 0.70 | 11.71% |
| 2023 | 0.63 | -4.03% |
| 2022 | 0.65 | -22.83% |
| 2021 | 0.85 | 3.64% |
| 2020 | 0.82 | -5.45% |
| 2019 | 0.86 | 8.73% |
| 2018 | 0.79 | -38.62% |
| 2017 | 1.29 | -11.82% |
| 2016 | 1.47 | -7.84% |
| 2015 | 1.59 | -35.53% |
| 2014 | 2.47 | 63.97% |
| 2013 | 1.51 | -4.54% |
| 2012 | 1.58 | 1.57% |
| 2011 | 1.55 | -42.84% |
| 2010 | 2.72 | -39.78% |
| 2009 | 4.51 | 103.81% |
| 2008 | 2.21 | -73.01% |
| 2007 | 8.20 | 53.64% |
| 2006 | 5.34 | 362.58% |
| 2005 | 1.15 | -5.59% |
| 2004 | 1.22 | 8.05% |
| 2003 | 1.13 | -35.55% |
| 2002 | 1.76 | -6.22% |
| 2001 | 1.87 | -38.50% |
| 2000 | 3.04 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 734.19% |
IN
|
